106 related articles for article (PubMed ID: 22516360)
1. Expression and clinical significance of von Hippel-Lindau downstream genes: Jade-1 and β-catenin related to renal cell carcinoma.
Lian X; Duan X; Wu X; Li C; Chen S; Wang S; Cai Y; Weng Z
Urology; 2012 Aug; 80(2):485.e7-13. PubMed ID: 22516360
[TBL] [Abstract][Full Text] [Related]
2. Candidate tumor suppressor and pVHL partner Jade-1 binds and inhibits AKT in renal cell carcinoma.
Zeng L; Bai M; Mittal AK; El-Jouni W; Zhou J; Cohen DM; Zhou MI; Cohen HT
Cancer Res; 2013 Sep; 73(17):5371-80. PubMed ID: 23824745
[TBL] [Abstract][Full Text] [Related]
3. Altered expression of beta-catenin in renal cell cancer and transitional cell cancer with the absence of beta-catenin gene mutations.
Bilim V; Kawasaki T; Katagiri A; Wakatsuki S; Takahashi K; Tomita Y
Clin Cancer Res; 2000 Feb; 6(2):460-6. PubMed ID: 10690524
[TBL] [Abstract][Full Text] [Related]
4. Regulation of E2F1 by the von Hippel-Lindau tumour suppressor protein predicts survival in renal cell cancer patients.
Mans DA; Vermaat JS; Weijts BG; van Rooijen E; van Reeuwijk J; Boldt K; Daenen LG; van der Groep P; Rowland BD; Jans JJ; Roepman R; Voest EE; van Diest PJ; Verhaar MC; de Bruin A; Giles RH
J Pathol; 2013 Sep; 231(1):117-29. PubMed ID: 23744542
[TBL] [Abstract][Full Text] [Related]
5. Expression of beta-catenin in renal cell carcinoma.
Zang T; Zhuang L; Zhang Z; Xin D; Guo Y
Chin Med J (Engl); 2001 Feb; 114(2):152-4. PubMed ID: 11780196
[TBL] [Abstract][Full Text] [Related]
6. Overproduction of vascular endothelial growth factor related to von Hippel-Lindau tumor suppressor gene mutations and hypoxia-inducible factor-1 alpha expression in renal cell carcinomas.
Na X; Wu G; Ryan CK; Schoen SR; di'Santagnese PA; Messing EM
J Urol; 2003 Aug; 170(2 Pt 1):588-92. PubMed ID: 12853836
[TBL] [Abstract][Full Text] [Related]
7. Correlation analysis of VHL and Jade-1 gene expression in human renal cell carcinoma.
Xiao-Fen W; Ting C; Jie L; Deng-Yang M; Qing-Feng Z; Xin L
Open Med (Wars); 2016; 11(1):226-230. PubMed ID: 28352799
[TBL] [Abstract][Full Text] [Related]
8. Methylation of the gamma-catenin gene is associated with poor prognosis of renal cell carcinoma.
Breault JE; Shiina H; Igawa M; Ribeiro-Filho LA; Deguchi M; Enokida H; Urakami S; Terashima M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):557-64. PubMed ID: 15701841
[TBL] [Abstract][Full Text] [Related]
9. SPOP promotes tumor progression via activation of β-catenin/TCF4 complex in clear cell renal cell carcinoma.
Zhao W; Zhou J; Deng Z; Gao Y; Cheng Y
Int J Oncol; 2016 Sep; 49(3):1001-8. PubMed ID: 27572476
[TBL] [Abstract][Full Text] [Related]
10. δ-Catenin regulates proliferation and apoptosis in renal cell carcinoma via promoting β-catenin nuclear localization and activating its downstream target genes.
Ju L; Shan L; Yin B; Song Y
Cancer Med; 2020 Mar; 9(6):2201-2212. PubMed ID: 31991069
[TBL] [Abstract][Full Text] [Related]
11. Expression of the angiopoietins and their receptor Tie2 in human renal clear cell carcinomas; regulation by the von Hippel-Lindau gene and hypoxia.
Currie MJ; Gunningham SP; Turner K; Han C; Scott PA; Robinson BA; Chong W; Harris AL; Fox SB
J Pathol; 2002 Dec; 198(4):502-10. PubMed ID: 12434420
[TBL] [Abstract][Full Text] [Related]
12. Jade-1 inhibits Wnt signalling by ubiquitylating beta-catenin and mediates Wnt pathway inhibition by pVHL.
Chitalia VC; Foy RL; Bachschmid MM; Zeng L; Panchenko MV; Zhou MI; Bharti A; Seldin DC; Lecker SH; Dominguez I; Cohen HT
Nat Cell Biol; 2008 Oct; 10(10):1208-16. PubMed ID: 18806787
[TBL] [Abstract][Full Text] [Related]
13. Jade-1: its structure, regulation and functions in the renal cancer.
Zhang YC; Du WQ; Zhang RY; Zheng JN; Pei DS
Curr Mol Med; 2016; 16(1):63-9. PubMed ID: 26695694
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of biallelic inactivation of the von Hippel-Lindau tumor suppressor gene VHL in patients of renal cell carcinoma patient].
Liu N; Gong K; Zhang N; Guo HF; Na X; Wu G; Na YQ
Zhonghua Wai Ke Za Zhi; 2005 Jan; 43(2):115-7. PubMed ID: 15771820
[TBL] [Abstract][Full Text] [Related]
15. Beta-catenin gets jaded and von Hippel-Lindau is to blame.
Berndt JD; Moon RT; Major MB
Trends Biochem Sci; 2009 Mar; 34(3):101-4. PubMed ID: 19217300
[TBL] [Abstract][Full Text] [Related]
16. [Correlation between the PTEN/MMAC1/TEP1 expression and cell proliferation and apoptosis in human renal cell carcinoma (RCC)].
Li JY; Cao RF; Wang H; Xie QX; Wang GX; Xiong LS; Miao YR
Ai Zheng; 2003 Jun; 22(6):607-11. PubMed ID: 12948410
[TBL] [Abstract][Full Text] [Related]
17. beta-catenin expression and mutational analysis in renal cell carcinomas.
Kim YS; Kang YK; Kim JB; Han SA; Kim KI; Paik SR
Pathol Int; 2000 Sep; 50(9):725-30. PubMed ID: 11012986
[TBL] [Abstract][Full Text] [Related]
18. Loss of expression of von Hippel-Lindau tumor suppressor protein associated with improved survival in patients with early-stage clear cell renal cell carcinoma.
Parker AS; Cheville JC; Lohse CM; Igel T; Leibovich BC; Blute ML
Urology; 2005 Jun; 65(6):1090-5. PubMed ID: 15893810
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.
Clifford SC; Prowse AH; Affara NA; Buys CH; Maher ER
Genes Chromosomes Cancer; 1998 Jul; 22(3):200-9. PubMed ID: 9624531
[TBL] [Abstract][Full Text] [Related]
20. Jade-1, a candidate renal tumor suppressor that promotes apoptosis.
Zhou MI; Foy RL; Chitalia VC; Zhao J; Panchenko MV; Wang H; Cohen HT
Proc Natl Acad Sci U S A; 2005 Aug; 102(31):11035-40. PubMed ID: 16046545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
